Dealing with the Corona Virus: The Case of the Pharma Industry

* Required Fields

Abstract

The pandemic induced lockdown lead to supply and manufacturing disruptions that were swiftly dealt with by the Indian Pharma Industry through successful industry-government collaboration. By May 2020 production was back to normal and exports were higher than the same period in May 2019. The case deals with the processes that enabled this to happen, the policy responses and the changes that happened in the period from March 2020 to August 2020.

Additional Information

Product Type Case
Reference No. PSG0139
Title Dealing with the Corona Virus: The Case of the Pharma Industry
Pages 46
Published on Apr 12, 2021
Year of Event 2020
Authors Sahay, Arvind; Joshi, Varuna M.;
Area Public Systems Group (PSG)
Discipline Public Policy and Law
Sector Government, Health, Trade
Learning Objective To understand the functions and structure of governing regulatory bodies with respect to the Indian pharmaceutical industry. To understand the structure of the pharmaceutical industry. To understand the mechanisms of interaction between the industry and the government. To follow the events that lead up to the pandemic and the government's response. To understand the operational and strategic issues that occurred during the lockdown.
Keywords Government-Industry Collaboration; Public Policy; Indian Pharma Industry; Pandemic Management
Country India
Access For All

My Cart

You have no items
in your shopping cart.